Table 2 Population characteristics of individuals from EAVE II who received at least the second (of the primary vaccination schedule) or a third dose of a COVID-19 vaccine
From: Accelerated waning of the humoral response to COVID-19 vaccines in obesity
Characteristic | Total vaccination (n, %) | Severe COVID-19 outcome (n, rate per 1,000 person-years) | |
|---|---|---|---|
Total | 3,588,340 (100.0) | 10,938 (6.0) | |
Sex | Female | 1,879,578 (52.4) | 5,528 (5.7) |
Male | 1,708,762 (47.6) | 5,455 (6.2) | |
Age group (years) | 18–49 | 1,634,424 (45.5) | 2,217 (2.5) |
50–64 | 1,021,352 (28.5) | 2,447 (4.6) | |
65–79 | 706,617 (19.7) | 3,331 (9.2) | |
80+ | 225,947 (6.3) | 2,988 (26.8) | |
BMI (kg/m2) | <18.5 | 36,197 (1.0) | 252 (13.7) |
18.5–24.9 | 456,128 (12.7) | 1,813 (7.7) | |
25–29.9 | 2,428,889 (67.7) | 5,599 (4.5) | |
30–39.9 | 568,420 (15.8) | 2,710 (9.3) | |
40+ | 98,706 (2.8) | 609 (12.2) | |
